Passage Bio, Inc. (PASG)
NASDAQ·Healthcare·Biotechnology
$5.77
+1.05%
Mkt Cap $27.94M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+4.0%
Consensus $6.00 vs current $5.77
NASDAQ·Healthcare·Biotechnology
$5.77
+1.05%
Mkt Cap $27.94M
No recent rating data.
Price Target (1 analysts)
$6.00
Range $6.00 – $6.00
+4.0%
Consensus $6.00 vs current $5.77